Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Ixekizumab Stories

2013-01-03 12:24:48

INDIANAPOLIS, Jan. 3, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that Michael P. Heffernan, M.D., a nationally recognized expert in complex medical dermatology, psoriasis and clinical trials, has joined its autoimmune team as distinguished medical fellow. Alisa E. Koch, M.D., a rheumatologist who has won numerous academic awards for her extensive work in rheumatoid arthritis, joined as senior medical fellow. Most recently, Heffernan was in private practice at Central...